Loading clinical trials...

A Study Of Milk Consumption In Metabolic Syndrome | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

A Study Of Milk Consumption In Metabolic Syndrome

Milk Consumption On Cardiovascular Risk Factors In Metabolic Syndrome

NCT07401888•Mayo Clinic

Summary

The primary purpose of this study is to determine the impact of whole-fat dairy consumption on cardiovascular and metabolic risk factors and peripheral vascular function in adults with metabolic syndrome.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. fasting plasma glucose ≥100 mg/dL (or medical therapy for elevated glucose)
•2. HDL-C \<40 mg/dL in men or \<50 mg/dL in women (or medical therapy for reduced HDL-C)
•3. Triglycerides ≥150 mg/dL (or medical therapy for elevated triglycerides)
•4. Waist circumference \>102 cm for men and \>88 cm for women
•5. Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg (or medical therapy for hypertension)

Exclusion Criteria

•1. Cardiovascular disease diagnosis
•2. Type 1 or 2 diabetes diagnosis
•3. Dairy allergy or lactose intolerance
•4. Self-reported high baseline dairy intake (\>3 servings per day)
•5. \>3 hours of physical activity per week
•6. Pregnant women
•7. Inflammatory bowel disease
•8. Chronic steroid use
•9. Allergy to metal
•10. GLP-1 agonist use
+1 more criteria

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Key Dates

Start Date

February 1, 2026

Primary Completion Date

February 1, 2028

Completion Date

February 1, 2028

Last Updated

February 11, 2026

Enrollment

ESTIMATED participants

Conditions

Metabolic Syndrome

Interventions

Full-fat diet

OTHER

Low-fat diet

OTHER

Contacts

Eric Bruhn

CONTACT

507-266-2690 bruhn.eric@mayo.edu

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

NCT07237750

Overweight and/or ObesityMetabolic Syndrome+2 more

View study

RECRUITINGNA

Effects of Cranberry on Gut and Metabolic Health

NCT07460856

Overweight/ObesityMetabolic Syndrome+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study Of Milk Consumption In Metabolic Syndrome

Inclusion Criteria

Exclusion Criteria

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

Effects of Cranberry on Gut and Metabolic Health

The Mom and Infant Outcomes (MOMI) Study

FEAST Perinatal Support Program Intervention

Assessing the Effect of an Antioxidant-Rich Diet on Metabolic Syndrome Risk Using the Dietary Antioxidant Index

Breath Mass Spectrometry in Metabolic Syndrome and Metabolically Healthy Obesity